Cargando…
Gut permeability and cognitive decline: A pilot investigation in the Northern Manhattan Study
BACKGROUND: Gut microbiota may impact cognitive function and decline, though data are limited. This pilot study examines the associations between gut dysbiosis products, plasma lipopolysaccharide (LPS) and soluble CD14 (sCD14), with cognitive decline and immune molecule activation among 40 participa...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186438/ https://www.ncbi.nlm.nih.gov/pubmed/34109319 http://dx.doi.org/10.1016/j.bbih.2021.100214 |
_version_ | 1783704951645536256 |
---|---|
author | Rundek, Tatjana Roy, Sabita Hornig, Mady Cheung, Ying Kuen Gardener, Hannah DeRosa, Janet Levin, Bonnie Wright, Clinton B. Del Brutto, Victor J. Elkind, Mitchell SV. Sacco, Ralph L. |
author_facet | Rundek, Tatjana Roy, Sabita Hornig, Mady Cheung, Ying Kuen Gardener, Hannah DeRosa, Janet Levin, Bonnie Wright, Clinton B. Del Brutto, Victor J. Elkind, Mitchell SV. Sacco, Ralph L. |
author_sort | Rundek, Tatjana |
collection | PubMed |
description | BACKGROUND: Gut microbiota may impact cognitive function and decline, though data are limited. This pilot study examines the associations between gut dysbiosis products, plasma lipopolysaccharide (LPS) and soluble CD14 (sCD14), with cognitive decline and immune molecule activation among 40 participants in the longitudinal population-based Northern Manhattan Study. METHODS: We selected stroke- and dementia-free participants at baseline with high activation levels of core components of the immune signaling pathways underlying microbiota metabolite-cognitive associations (IL-1, IL-17, TNF). Participants were followed with up to three complete neuropsychological assessments, at least 5 years apart. RESULTS: Elevated sCD14 was associated with high levels of IL-1 pathway activation (p < 0.05), whereas in samples where only those molecules within the IL-17 and TNF pathways were increased, LPS and sCD14 levels were not elevated. LPS was associated with decline in global cognitive performance over 2–3 assessments (adjusted β = -0.023 per SD per year, 95% CI:-0.036, −0.010). The association between sCD14 and cognitive decline was marginal (adjusted β = -0.018 per SD per year, 95% CI:-0.040, 0.004). CONCLUSIONS: These preliminary data support the hypothesis that gut dysbiosis leads to systemic and neuro-inflammation, and subsequently cognitive decline. Further large targeted and untargeted gut microbiota-derived metabolomic studies are needed. |
format | Online Article Text |
id | pubmed-8186438 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-81864382021-06-08 Gut permeability and cognitive decline: A pilot investigation in the Northern Manhattan Study Rundek, Tatjana Roy, Sabita Hornig, Mady Cheung, Ying Kuen Gardener, Hannah DeRosa, Janet Levin, Bonnie Wright, Clinton B. Del Brutto, Victor J. Elkind, Mitchell SV. Sacco, Ralph L. Brain Behav Immun Health Short Communication BACKGROUND: Gut microbiota may impact cognitive function and decline, though data are limited. This pilot study examines the associations between gut dysbiosis products, plasma lipopolysaccharide (LPS) and soluble CD14 (sCD14), with cognitive decline and immune molecule activation among 40 participants in the longitudinal population-based Northern Manhattan Study. METHODS: We selected stroke- and dementia-free participants at baseline with high activation levels of core components of the immune signaling pathways underlying microbiota metabolite-cognitive associations (IL-1, IL-17, TNF). Participants were followed with up to three complete neuropsychological assessments, at least 5 years apart. RESULTS: Elevated sCD14 was associated with high levels of IL-1 pathway activation (p < 0.05), whereas in samples where only those molecules within the IL-17 and TNF pathways were increased, LPS and sCD14 levels were not elevated. LPS was associated with decline in global cognitive performance over 2–3 assessments (adjusted β = -0.023 per SD per year, 95% CI:-0.036, −0.010). The association between sCD14 and cognitive decline was marginal (adjusted β = -0.018 per SD per year, 95% CI:-0.040, 0.004). CONCLUSIONS: These preliminary data support the hypothesis that gut dysbiosis leads to systemic and neuro-inflammation, and subsequently cognitive decline. Further large targeted and untargeted gut microbiota-derived metabolomic studies are needed. Elsevier 2021-01-29 /pmc/articles/PMC8186438/ /pubmed/34109319 http://dx.doi.org/10.1016/j.bbih.2021.100214 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Short Communication Rundek, Tatjana Roy, Sabita Hornig, Mady Cheung, Ying Kuen Gardener, Hannah DeRosa, Janet Levin, Bonnie Wright, Clinton B. Del Brutto, Victor J. Elkind, Mitchell SV. Sacco, Ralph L. Gut permeability and cognitive decline: A pilot investigation in the Northern Manhattan Study |
title | Gut permeability and cognitive decline: A pilot investigation in the Northern Manhattan Study |
title_full | Gut permeability and cognitive decline: A pilot investigation in the Northern Manhattan Study |
title_fullStr | Gut permeability and cognitive decline: A pilot investigation in the Northern Manhattan Study |
title_full_unstemmed | Gut permeability and cognitive decline: A pilot investigation in the Northern Manhattan Study |
title_short | Gut permeability and cognitive decline: A pilot investigation in the Northern Manhattan Study |
title_sort | gut permeability and cognitive decline: a pilot investigation in the northern manhattan study |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186438/ https://www.ncbi.nlm.nih.gov/pubmed/34109319 http://dx.doi.org/10.1016/j.bbih.2021.100214 |
work_keys_str_mv | AT rundektatjana gutpermeabilityandcognitivedeclineapilotinvestigationinthenorthernmanhattanstudy AT roysabita gutpermeabilityandcognitivedeclineapilotinvestigationinthenorthernmanhattanstudy AT hornigmady gutpermeabilityandcognitivedeclineapilotinvestigationinthenorthernmanhattanstudy AT cheungyingkuen gutpermeabilityandcognitivedeclineapilotinvestigationinthenorthernmanhattanstudy AT gardenerhannah gutpermeabilityandcognitivedeclineapilotinvestigationinthenorthernmanhattanstudy AT derosajanet gutpermeabilityandcognitivedeclineapilotinvestigationinthenorthernmanhattanstudy AT levinbonnie gutpermeabilityandcognitivedeclineapilotinvestigationinthenorthernmanhattanstudy AT wrightclintonb gutpermeabilityandcognitivedeclineapilotinvestigationinthenorthernmanhattanstudy AT delbruttovictorj gutpermeabilityandcognitivedeclineapilotinvestigationinthenorthernmanhattanstudy AT elkindmitchellsv gutpermeabilityandcognitivedeclineapilotinvestigationinthenorthernmanhattanstudy AT saccoralphl gutpermeabilityandcognitivedeclineapilotinvestigationinthenorthernmanhattanstudy |